PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.
President
PharmaLex provides support across the value chain of pharmaceutical companies worldwide. 25 years of extensive experience in supporting our clients on critical projects has helped us to establish a network of local representatives in the MENA region who enable us to support our clients in the region.
Our value-driven clients solutions in MENA include:
Our Global Alliance Partner network, provides access to experienced local representatives who are professionals and leaders in their field of expertise and respective regions.
PharmaLex’s customer-centric approach provides better experience to our clients with dedicated resources supporting on the agreed business deliverables while ensuring timelines are met.
We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.
PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.
We couldn’t have asked for a more professional, personable, knowledgeable group of Quality Experts!
Provided honest feedback and collaborative working solutions to obstacles
I have found the quality of both work and personnel to be unparalleled. Rina and the team have taken much time and care to understand our business and brand objectives. They have worked tirelessly to assist with a solutions-based focus and have maintained extremely high standards to support us. I cannot imagine another supplier providing this level of service.
Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.
We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.
Many thanks for your understanding.
The PharmaLex Team
We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for